Apical periodontitis is an infection of the tooth root apex resulting from the inflammatory response to bacteria that have migrated through the dental pulp ([@CIT0001], [@CIT0002]). When left untreated, the inflammatory response typically manifests in walling off the bacterial invaders by formation of a periapical lesion (granuloma) ([Fig. 1](#F0001){ref-type="fig"}). The treatment of apical periodontitis commonly involves tooth extraction, curettage and irrigation, followed by installation of a dental implant. Peri-implantitis, or the destructive inflammation of soft and hard tissues around dental implants and associated microbial challenge, is a cause of dental implant failure ([@CIT0003], [@CIT0004]). Current 20-year follow-up studies suggest that 99% of implants remain osseointegrated after 1 year, but this drops to 93% after 5 years ([@CIT0005]).

![Sampling areas and debridement summary at time 0 (white circle) and 6 months (black circle). Of the two periapical lesions (granulomas) pictured in the example radiograph, one features in the white circle. Where possible, sampling was made below the periapical lesion, into trabecular bone (black circle). A reference buccal supragingival biofilm sample from tooth 27 is not shown in the sampling scheme.](MEHD-27-31307-g001){#F0001}

Complex bacterial populations exist in the healthy human oral cavity, hosting 500--700 different bacterial species, with 100--200 different species present in any individual, mostly classified within six phyla ([@CIT0006], [@CIT0007]). Such complexity in membership makes it difficult to distinguish the roles of specific bacterial species during health and disease. Nevertheless, certain bacteria are overrepresented at specific sites during various pathologies of the oral cavity ([@CIT0008]--[@CIT0010]). For example, the bacterial genera *Prevotella*, *Porphyromonas* and *Fusobacterium* tend to be overrepresented in infections of the pulp ([@CIT0007], [@CIT0010]). Slight increases of *Prevotella* on failed implants with respect to healthy teeth have been detected ([@CIT0009]). It has been suggested that bacterial colonisation through the internal cavity of dental implants is a way in which peri-implantitis can begin ([@CIT0011]).

Previously, it has been demonstrated that viable bacteria reside in alveolar bone adjacent to the former tooth root apex, including *Actinomyes* and *Prevotella* spp ([@CIT0012]). The presence of low numbers of bacteria in a normally sterile site (alveolar bone) raised the possibility that these bacteria may later proliferate, contributing to peri-implantitis and early failure of osseointegrated dental implants ([@CIT0012]). Given the difficulties in culturing bacteria of the oral cavity, this study aimed to compare the bacteria associated with alveolar bone, apical periodontitis and dental implant failure with reference biofilm samples from healthy teeth via a molecular profiling approach, specifically, comparison of bacterial communities using terminal restriction fragment length polymorphism (T-RFLP) and 454 pyrosequencing of 16S rDNA in diseased samples (root canal, granulomas, alveolar bone and a failed implant).

Materials and methods {#S0002}
=====================

Patient selection and sample collection {#S0002-S20001}
---------------------------------------

This study was conducted on 40 routine private practice patients presenting for dental implant insertion or rehabilitation. Approval for surgery and sampling was obtained from the University of Sydney Human Research Ethics Committee. Surgical procedures and sampling were performed by a calibrated clinician, following a previously described strictly aseptic two-stage open-flap surgical technique ([@CIT0012], [@CIT0013]) summarised in [Fig. 1](#F0001){ref-type="fig"}.

Immediately prior to surgery, a reference sample of normal microflora \[supragingival buccal biofilm scraping of tooth 27 (UL7)\] was made. Following biofilm sampling, during the first 'preparatory' stage (time point 0), microorganisms were removed and soft granulation tissue was curetted using spoon excavators and a Mitchell Osseo Trimmer (Medident, Braeside, Australia). Some bone samples were taken at the height of the former periapex, which was determined by measurements of the extracted calibrated lengths from digital radiographs and radiographic confirmation with the preparation drill *in situ*. Overlying bone was debrided with a guide drill to the height of the former tooth root apex (also at time point 0). A twist drill was used to penetrate the former tooth root apex into trabecular bone. Debridement of overlying trabecular and cortical bone was performed with a Brånemark System round guide drill equipped with a shaft extender under chilled, sterile saline. Extreme care was taken to prevent contamination of drill bits in sample sites from other areas of the oral cavity. In the second stage (6 months after initial debridement), the previously apparently healed debrided sites were re-debrided in preparation for abutment connection (implant insertion). After measuring the depth of the implant site, implants were mechanically inserted. During curettage and debridement procedures, blood and tissue fluids were absorbed on a size 80 endodontic paper point (Dentsply Maiellefer, Ballaigues, Switzerland), which was left in the sample site for 15 sec. Entire drill bits (with retained bone fragments) used to debride bone or bone filter particles suctioned out of the sample site were retained for analyses, whereas present, intact granulomas, a failed implant or infected tooth were sampled directly. Samples were added to chilled TE buffer (0.5 ml, 10 mM Tris, 1 mM EDTA, pH 7.6) and transported to the molecular laboratory on ice, before storage at −80°C, until DNA extraction. Where patients fell within the study time constraints, at 6 months, apparently healed bone of the implant site was re-debrided and sampled by paper point, bone directly retained on drill bits or bone filter particles suctioned out of the sample site. A total of 196 samples were taken from 104 sites. The failed titanium implant (a 5×7 mm WP Branemark MK 111 TiUnite) presented with bone loss 8 months after prosthetic connection. Other relevant sample details are documented in [Supplementary Table 1](#S1){ref-type="supplementary-material"}.

DNA extraction {#S0002-S20002}
--------------

DNA was extracted by bead-beating samples at 5.5 ms^−1^ for 30 sec (Fast Prep FP-120, Bio101), followed by purification as described previously ([@CIT0014]). Samples were bead-beat to aid lysis of Gram-positive bacteria. One extraction blank, consisting of sterile TE buffer, was included for every 10 samples. DNA quality and quantity was verified by agarose gel electrophoresis.

Terminal Restriction Fragment Length Polymorphism {#S0002-S20003}
-------------------------------------------------

The extracted DNA was polymerase chain reaction (PCR) amplified using bacterial domain-specific primers, targeting variable regions V1--V5 of the bacterial 16S rRNA gene, using primers 27F (5′-AGAGTTTGATYMTGGCTCAG) and 907R (5′-CCGTCAATTCMTTTRAGTTT), which were modified at the 5′ end with 5-FAM and 6-HEX fluorophores, respectively. Each 25 µl PCR reaction contained 1×Thermopol buffer, 1 µM of forward and reverse primers, 200 µM dNTPs and 1.25 U Taq DNA polymerase. All reagents for PCR amplification and digestion were supplied by New England Biolabs (Ipswich, MA, USA). PCR conditions included an initial denaturation of 94°C for 4 min, then 30 cycles of 94°C for 30 sec, 51°C for 45 sec and 72°C for 60 sec, followed by a final extension at 72°C for 10 min on a Mastercycler S machine (Eppendorf, Hamburg, Germany).

PCR amplicons were separately digested with HaeIII (10U) and MspI (20U), and the resultant terminal restriction fragments (T-RFs) were analysed by capillary electrophoresis using an ABI PRISM 3730 DNA Analyser (AGRF, Westmead, Australia). Genemapper v3.7 (Applied Biosystems, Foster City, CA, USA) was used to determine peak length, height and area using the Local Southern algorithm. T-RFs \<50bp or ≤1% of the total fluorescent area were excluded from analysis. For the four combinations of fluorophore and restriction enzyme, remaining T-RFs were rounded to the nearest integer and Primer VI (v. 6.1.6, Primer-E Ltd, Auckland, New Zealand) was used to convert TRFs into a presence and absence matrix. Non-metric multidimensional scaling (NMDS) using the Bray--Curtis coefficient ([@CIT0015]), with a restart value of 200 and a one way analysis of similarities (ANOSIM) with a maximum permutation of 9,999, was carried out ([@CIT0016]). Samples were separated based on association with health and disease.

Pyrosequencing and sequence analysis {#S0002-S20004}
------------------------------------

Genomic DNA from eight samples was sent to Research and Testing Laboratory (RTL, Lubbock, TX, USA) for amplification with primers 28F (5′-AGTTTGATCNTGGCTCAG) and 519R (5′-GTNTTACNGCGGCKGCTG) appended with DNA 'bar codes' described previously ([@CIT0017]). Sequencing of V1--V3 hypervariable regions of the 16S rRNA was performed by the RTL, using a Roche GS-FLX^+^ Sequencer with Titanium reagents (Roche, Indianapolis, USA) from 28F. Sequences were demultiplexed by RTL, giving 44,211 sequences.

Sequences were processed with mothur following an established 454 pyrosequencing analysis pipleine \[([@CIT0018]), described in detail at: [www.mothur.org/wiki/454_SOP](http://www.mothur.org/wiki/454_SOP))\]. Sequence barcodes and primers were removed and sequences were truncated if they fell below an average quality threshold of 30 over a sliding window of 50 base pairs. Quality-trimmed sequences were aligned against the mothur-formatted SILVA bacterial reference alignment. Chimeric sequences were removed with uchime and sequences were merged together ('preclustered', diffs = 2) if they differed by less than 4 bases ([@CIT0019]). Sequences were classified with the mothur-formatted Greengenes 16S rDNA reference taxonomy. Within sequences that passed quality filtering were converted to a percentage of the total sequences within each sample (summarised in [Supplementary Table 2](#S1){ref-type="supplementary-material"}). Taxa with less than 0.5% abundance in a given sample are not shown. The average and standard error of the mean were calculated for remaining taxa within each sample type. In preparation for statistical analyses, a similarity matrix was generated using Bray--Curtis coefficient. To avoid bias in analyses, the similarity matrix was subsampled to 1,189 sequences per sample. To analyse variation in community structure, samples were grouped into reference biofilms (*n*=3) or diseased (*n*=5) bins and analysis of molecular variance (AMOVA) was used with 1,000 permutations ([@CIT0020]). The mothur implementation of metastats ([@CIT0021]) was also used to determine if any operational taxonomic units (OTUs) were significantly different in reference biofilm and diseased samples.

Results {#S0003}
=======

PCR amplification of 16S rRNA gene {#S0003-S20001}
----------------------------------

A total of 196 samples were collected from 40 patients undergoing dental implant preparation and/or insertion. The disease-associated sample set included granulomas, a failed implant, tooth fragments, paper points soaked with extruded fluids and drill bits with attached tissue. Buccal supragingival biofilm scrapings collected from non-diseased teeth were used as references for a normal oral bacterial community.

All dental biofilm samples from healthy teeth yielded strong PCR products, but it proved difficult to amplify 16S rRNA genes from other samples. Attempts to improve the PCR using chemical facilitators (betaine, dimethyl sulfoxide, bovine serum albumin), different polymerases (Kapa 'Blood Taq'; Kapa Biosystems, Wilmington, USA), different template dilutions, different primer sets or modified thermocycling conditions were not successful (data not shown). Addition of a multiple displacement amplification step (Repli-G mini kit, Qiagen, Hilden, Germany) before the PCR enabled amplification of a few difficult templates, but subsequent T-RFLP and NMDS analyses showed that these samples clustered erroneously, with few terminal fragments; therefore, this approach was not pursued further (data not shown). Further T-RFLP analyses were performed on samples that yielded sufficient PCR products (31 of 196 samples) consisting of intact granulomas (*n*=2), bone fragments (*n*=1), an infected tooth (*n*=1), a failed implant (*n*=1), paper points (*n*=5) or healthy tooth biofilms (*n*=21).

T-RFLP analysis: reference and diseased communities {#S0003-S20002}
---------------------------------------------------

T-RFLP provides a snapshot of community structure based on the size of T-RFs produced from amplified ribosomal RNA genes. For both restriction enzymes (HaeIII, MspI) and fluorophores (5'-FAM, 3'-HEX) used, the same general pattern was observed, that is, the biofilm samples from reference teeth consistently grouped together, separately from diseased tissue samples ([Fig. 2](#F0002){ref-type="fig"}), a result confirmed by ANOSIM analysis, in which all four combinations of fluorophore and restriction enzymes were significantly separated ([Fig. 2](#F0002){ref-type="fig"}). The number of terminal fragments obtained using Msp1 (17.6±5.7) was similar to that obtained using HaeIII (16.5±5). Taken together, the T-RFLP data indicated that the bacterial communities in the diseased samples were different from that in the reference biofilm samples. Eight of the samples were analysed in greater detail by pyrosequencing of the 16S rDNA gene (regions V1--V3).

![Non-metric multidimensional scaling of T-RFLP data from reference biofilm versus diseased samples. (a) 5′-FAM label/HaeIII digest (stress = 0.22, *p*\<0.01), (b) 5′-FAM/MspI digest (stress = 0.26, *p*\<0.01), (c) 3′-HEX label/HaeIII digest (stress = 0.20, *p*\<0.01) and (d) 3′-HEX label/MspI digest (stress = 0.23, *p*\<0.02). Reference biofilm and diseased samples are represented by grey and blue triangles, respectively. Technical replicates (amplification and digestion performed in triplicate) of biofilm samples 22A and 23A have yellow or green centres, respectively.](MEHD-27-31307-g002){#F0002}

Pyrosequencing analysis: community patterns {#S0003-S20003}
-------------------------------------------

A total of 44,211 sequences were generated from eight samples. Of these sequences, 57% (25,189) passed strict quality control filters ([Supplementary Table 2](#S1){ref-type="supplementary-material"}), yielding 11,248 sequences associated with reference biofilm samples (average 3,749±277 per sample) and 11,097 sequences associated with diseased samples (average 2,219±638 per sample). A total of 2,464 unique sequences were clustered at the 97% similarity threshold, giving 373 OTUs across all samples ([Supplementary Table 3](#S1){ref-type="supplementary-material"}). The total diversity found in disease-associated samples (278±26 OTUs per sample) was higher than that of healthy tooth biofilms (216±12 OTUs per sample). However, within patients, the abundance of bacteria from reference samples was always higher than corresponding diseased sample (see below and also rarefaction curves in [Supplementary Fig. 1](#S1){ref-type="supplementary-material"}). An AMOVA revealed that reference and diseased bacterial populations were significantly different (*p*\<0.049). In the eight patients combined, the most abundant phyla were Actinobacteria (24%), Fusobacteria (23%), Firmicutes (20%), Proteobacteria (18%) and Bacteroidetes (10%) ([Fig. 3](#F0003){ref-type="fig"}). Low abundance phyla included Synergistetes (1.7%), Spirochaetes (1.3%), TM7 (0.8%), GN02 (0.1%), SR1 (0.1%), Tenericutes (0.1%), Gemmatimonadetes (0.04%) and AD3 (0.04%). Synergistetes, SR1, Tenericutes, Gemmatimonadetes and AD3 were only detected in disease-associated samples, some of which, such as Synergistetes (*TG5*), are either not yet culturable or difficult to culture ([@CIT0022]).

![Relative 16S rDNA sequence abundances of bacteria in reference biofilm versus diseased samples. The taxonomic results from 454 pyrosequencing at the phylum-level resolution. Sample types are biofilm (B), granuloma (G), infected tooth (T), root canal (RC) and failed implant (I) from 6 patients (18E/18G, 2A, 6A, 23B, 24A and 35A/35C). The columns labelled 'Reference' and 'Disease' show the average sequence abundances in these data sets (*n*=3 and *n*=5, respectively). 'Other' includes GN02, SR1, Tenericutes, Gemmatimonadetes and AD3.](MEHD-27-31307-g003){#F0003}

Pyrosequencing analysis: bacterial types associated with disease {#S0003-S20004}
----------------------------------------------------------------

The relative abundance of sequences detected in all samples is shown in [Table 1](#T0001){ref-type="table"} and [Fig. 3](#F0003){ref-type="fig"}. Some of the major trends in the diseased samples were decreases in abundance of sequences from *Actinomyces* (eightfold), *Corynebacterium* (sixfold) and *Streptococcus* (fivefold), and increases in abundance of sequences from *Fusobacterium* and *Prevotella* (both sevenfold). *TG5*, a clade within the Synergistetes phylum, was detected only in diseased tissues, comprising an average of 3.4% of sequences in these communities. Of these changes, metastats identified *Fusobacterium* (OTU 1) and *Corynebacterium* (OTU 5) as significant (*p*\<0.004 and *p*\<0.008, respectively) between all reference and disease-associated samples.

###### 

Relative sequence abundances (16S rDNA) of bacterial taxa in reference biofilm and diseased dental samples[a](#TF0001){ref-type="table-fn"}[b](#TF0002){ref-type="table-fn"}

                                                            Abundance (%)   
  --------------------------------------------------------- --------------- ----------
  Actinobacteria Actinomycetaceae *Actinomyces*             26.1±4.3        3.3±0.3
  Firmicutes Streptococcaceae *Streptococcus*               20.2±5.9        3.8±0.2
  Actinobacteria Corynebacteriaceae *Corynebacterium*       13.3±1.3        2.2±0.4
  Fusobacteria Fusobacteriaceae *Fusobacterium*             5.2±1.5         38.3±2.6
  Bacteroidetes Flavobacteriaceae *Capnocytophaga*          4.0±0.6         3.8±0.7
  Proteobacteria Neisseriaceae *Neisseria*                  3.5±0.6         4.0±0.8
  Firmicutes Veillonellaceae *Veillonella*                  3.0±0.2         2.8±0.4
  Proteobacteria Burkholderiaceae *Lautropia*               2.5±0.4         7.0±1.4
  Proteobacteria Campylobacteraceae *Campylobacter*         2.4±0.5         3.5±0.3
  Fusobacteria Fusobacteriaceae *Leptotrichia*              2.3±0.4         0.7±0.1
  Firmicutes Carnobacteriaceae *Granulicatella*             2.2±0.7         0.1±0.0
  Proteobacteria Pasteurellaceae *Haemophilus*              2.0±0.3         1.3±0.3
  Firmicutes Veillonellaceae *Selenomonas*                  1.9±0.5         1.3±0.2
  Bacteroidetes Porphyromonadaceae *Porphyromonas*          1.3±0.4         0.1±0.0
  Bacteroidetes Prevotellaceae *Prevotella*                 1.2±0.3         8.9±1.1
  Proteobacteria Neisseriaceae *Kingella*                   1.1±0.0         0.2±0.0
  Proteobacteria Neisseriaceae *Eikenella*                  1.0±0.3         0.5±0.1
  TM7 Unclassified                                          1.0±0.2         0.5±0.1
  Actinobacteria Propionibacteriaceae *Propionibacterium*   1.0±0.3         0.1±0.1
  Firmicutes Gemellaceae *Gemella*                          0.9±0.3         0.1±0.0
  Actinobacteria Micrococcaceae *Rothia*                    0.7±0.1         0.3±0.1
  Proteobacteria Pasteurellaceae *Aggregatibacter*          0.5±0.1         2.0±0.3
  Spirochaetes Spirochaetaceae *Treponema*                  0.2±0.1         2.4±0.3
  Proteobacteria Cardiobacteriaceae *Cardiobacterium*       0.2±0.0         0.6±0.1
  Bacteroidetes Porphyromonadaceae *Tannerella*             0.2±0.1         0.7±0.1
  Synergistes Dethiosulfovibrionaceae *TG5*                 0.0±0.0         3.4±0.5
  Actinobacteria Coriobacteriaceae *Atopobium*              0.0±0.0         0.5±0.1
  Firmicutes Peptostreptococcaceae *Filifactor*             0.0±0.0         0.5±0.2

Only OTUs of \>0.5% abundance in at least one sample group are shown.

Taxa are arranged from highest to lowest abundance in the reference biofilm data set.

A comparison of one reference sample (biofilm, 18E) and one diseased sample (granuloma, 18G) from the same patient is shown in [Table 2](#T0002){ref-type="table"} and [Supplementary Table 4](#S1){ref-type="supplementary-material"}. The majority of OTUs (75%) from the granuloma corresponded to sequence types in the biofilm, at ≥97% sequence identity, indicating the granuloma bacteria were a subset of this patient\'s biofilm community. Increases in *Prevotella* and *Fusobacterium* and decreases in Actinobacteria (*Actinomyces* and *Corynebacterium*) were observed in the granuloma relative to the biofilm control (Sample 18E). Other notable features of the granuloma were increases in *Veillonella* and *Atopobium* sequences (6-fold and 29-fold, respectively) and decreases in *Capnocytophaga* and *Neisseria* sequences (11-fold and 52-fold, respectively), relative to biofilm.

###### 

Bacterial taxa in biofilm (18E) and granuloma (18G) from the same patient[a](#TF0003){ref-type="table-fn"}[b](#TF0004){ref-type="table-fn"}

                                                            Abundance (%)   
  --------------------------------------------------------- --------------- ------
  Fusobacteria Fusobacteriaceae *Fusobacterium*             15.7            33.4
  Actinobacteria Actinomycetaceae *Actinomyces*             15.3            8.2
  Actinobacteria Corynebacteriaceae *Corynebacterium*       13.8            0.2
  Bacteroidetes Flavobacteriaceae *Capnocytophaga*          7.8             0.7
  Firmicutes Veillonellaceae *Selenomonas*                  5.4             8.8
  Proteobacteria Campylobacteraceae *Campylobacter*         5.4             6.0
  Proteobacteria Neisseriaceae *Neisseria*                  5.2             0.1
  Bacteroidetes Porphyromonadaceae *Porphyromonas*          3.8             0.0
  Actinobacteria Propionibacteriaceae *Propionibacterium*   3.2             0.0
  Firmicutes Streptococcaceae *Streptococcus*               3.3             3.4
  Firmicutes Veillonellaceae *Veillonella*                  3.2             20.7
  Proteobacteria Neisseriaceae *Eikenella*                  3.2             0.0
  Bacteroidetes Prevotellaceae *Prevotella*                 3.1             12.6
  TM7 unclassified                                          1.7             0.8
  Proteobacteria Pasteurellaceae *Aggregatibacter*          1.6             0.0
  Proteobacteria Neisseriaceae *Kingella*                   1.3             0.0
  Spirochaetes Spirochaetaceae *Treponema*                  0.6             0.0
  Proteobacteria Pasteurellaceae *Haemophilus*              0.5             0.0
  Actinobacteria Coriobacteriaceae *Atopobium*              0.1             2.9
  Tenericutes Erysipelotrichaceae *Bulleidia*               0.0             0.5

Only OTUs of \>0.5% abundance in at least one sample group are shown.

Taxa are arranged from highest to lowest abundance in the biofilm data set.

Sequences in a granuloma from a different patient (Sample 2A, [Fig. 3](#F0003){ref-type="fig"} and [Supplementary Table 6](#S1){ref-type="supplementary-material"}) confirmed some of the trends observed in granuloma 18G. In Sample 2A, *Fusobacterium* was the most abundant sequence type (69.4%), *Prevotella* sequences were more abundant compared with their average abundance in biofilm samples and Actinobacteria decreased in reference to biofilm samples. An unusual feature of the granuloma 2A was that bacteria from phylum *TG5* were quite abundant, at 5.5% of all sequences. *TG5* sequences were not detected in granuloma 18G, or in any of the biofilm samples, but were detected in the failed implant (Sample 35C, discussed below).

A comparison of the sequences recovered from a failed dental implant (35C) and a biofilm sample (35A) from the same patient ([Table 3](#T0003){ref-type="table"}, [Supplementary Table 5 and Fig. 3](#S1){ref-type="supplementary-material"}) revealed similar shifts in bacterial genera as were seen in the granuloma samples, with an increase in *Prevotella* and *Fusobacterium* sequences (39-fold and 53-fold, respectively) and a decrease in sequences from Actinobacteria, specifically, complete loss of *Corynebacterium*, and 10-fold decrease in *Actinomyces*. Other notable trends in the failed implant community included the appearance of *TG5* and *Treponema*, an increase in *Campylobacter* sequences (54-fold) and a decrease in *Streptococcus* (14-fold). A significant portion (4.7%) of the sequences from the failed implant community mapped to the domain Bacteria, but could not confidently be assigned into any known phylum.

###### 

Bacterial taxa in healthy tooth biofilm (35A) and failed implant (35C) from the same patient[a](#TF0005){ref-type="table-fn"}[b](#TF0006){ref-type="table-fn"}

                                                        Abundance (%)   
  ----------------------------------------------------- --------------- ------
  Firmicutes Streptococcaceae *Streptococcus*           48.4            3.4
  Actinobacteria Actinomycetaceae *Actinomyces*         11.2            1.1
  Actinobacteria Corynebacteriaceae *Corynebacterium*   6.2             0.0
  Firmicutes Carnobacteriaceae *Granulicatella*         5.6             0.0
  Proteobacteria Burkholderiaceae *Lautropia*           4.1             0.0
  Fusobacteria Fusobacteriaceae *Leptotrichia*          3.3             0.0
  Firmicutes Gemellaceae *Gemella*                      2.3             0.2
  Firmicutes Veillonellaceae *Veillonella*              1.9             0.0
  Actinobacteria Micrococcaceae *Rothia*                1.3             0.0
  Bacteroidetes Flavobacteriaceae *Capnocytophaga*      1.2             0.0
  Proteobacteria Neisseriaceae *Kingella*               1.0             0.0
  Fusobacteria Fusobacteriaceae *Fusobacterium*         0.8             42.4
  Bacteroidetes Prevotellaceae *Prevotella*             0.5             19.3
  Proteobacteria Campylobacteraceae *Campylobacter*     0.1             5.4
  Proteobacteria Pasteurellaceae *Aggregatibacter*      0.1             2.4
  Firmicutes Veillonellaceae *Dialister*                0.0             1.3
  Firmicutes Peptococcaceae *Peptococcus*               0.0             0.9
  Actinobacteria Coriobacteriaceae *Atopobium*          0.0             0.7
  Firmicutes Clostridiaceae *Mogibacterium*             0.0             0.5
  Firmicutes Clostridiaceae *Eubacterium*               0.0             0.5

Only OTUs of \>0.5% abundance in at least one sample group are shown.

Taxa are arranged from highest to lowest abundance in the reference biofilm data set.

Pyrosequencing analyses of an infected tooth (Sample 6A, [Supplementary Table 7](#S1){ref-type="supplementary-material"}), a root canal paper point sample (23B, [Supplementary Table 8](#S1){ref-type="supplementary-material"}) and another reference biofilm sample (24A, [Supplementary Table 9](#S1){ref-type="supplementary-material"}) reinforced many of the trends of the failed implant bacterial community, especially the increased abundance of *Fusobacterium* and the decreased abundance of Actinobacteria in the diseased samples (see also [Fig. 3](#F0003){ref-type="fig"}).

Discussion {#S0004}
==========

A molecular profiling approach was used to investigate bacteria associated with a failed dental implant, apical periodontitis and alveolar bone. Several characteristic features of the bacterial communities associated with implant failure and periodontitis were defined, including an increased relative abundance of *Prevotella* and *Fusobacterium* and a decreased abundance of *Actinomyces* and *Corynebacterium* relative to the biofilm on reference teeth. The reference biofilm and disease-associated bacterial communities were distinguished by community profiling using T-RFLP, and these differences were confirmed by pyrosequencing.

Great difficulty was encountered in amplifying 16S rDNA from the majority of blood and bone-containing samples. Using 454 pyrosequencing, a similar phenomenon in root canal samples has been noted and attributed to competitive inhibition by human DNA ([@CIT0008]). In that study, poor PCR amplification was overcome by diluting template DNA, but this approach was not successful for our samples. Two lines of evidence suggest that our PCR amplification difficulties were primarily because of low numbers of bacteria; firstly, biofilm samples and obviously infected samples (such as granulomas) gave strong PCR products, and secondly, human ribosomal sequences (18S rDNA) could be amplified from many samples which did not give positive 16S rDNA PCRs (data not shown). On the other hand, PCRs using a mixture of amplifiable and non-amplifiable templates gave similar results to the non-amplifiable templates alone (data not shown), suggesting the presence of PCR inhibitors was a contributing factor. Calcium ions ([@CIT0023]) from bone, or blood factors, such as immunoglobulin G or lactoferrin ([@CIT0024]), may have contributed to the problems with PCR amplification and detection of bacteria in many samples.

Previous culture-based work detected an increased abundance of *Actinomyces* and *Prevotella* spp. in cases of apical periodontitis and on failed dental implants ([@CIT0012]). This trend was not revealed by pyrosequencing analyses performed herein, which showed a decreased relative abundance of Actinobacteria (*Actinomyces* and *Corynebacterium*). This apparent discrepancy may represent the ease of culturing facultatives (such as *Actinomyces*) compared with strict anaerobes (*Fusobacterium*) ([@CIT0025]) which may bias apparent viable counts of these clades. It is notable that the shifts in taxa seen between reference biofilm and diseased samples in this study correlate to a large extent with a shift from facultatives to strict anaerobes. This trend underlines the usefulness of pyrosequencing for studying samples that contain unculturable or fastidious bacteria, where taxa detected in the diseased samples may have been overlooked or underrepresented in a culture-based study.

One of the most striking patterns observed in the pyrosequencing data was the high relative abundance of *Fusobacterium* sequences in all of the diseased samples. *Prevotella* populations also increased in diseased samples with an average 20-fold increase in this genus (19.3%) in the failed implant compared to the average detected on reference biofilm. Using pyrosequencing, other investigators confirmed that failed implants are dominated by Gram-negative bacteria ([@CIT0009]). However, whilst *Prevotella* populations associated with failed implants increased with respect to reference biofilm, the same investigators detected the highest populations of *Prevotella* on healthy implants ([@CIT0009]). Other taxa that tended to be more abundant in diseased samples than in reference biofilm samples were *Treponema*, Veillonellaceae (*Selenomonas* and *Veillonella*) and Synergistetes (*TG5*), all bacteria detected during chronic periodontitis ([@CIT0026], [@CIT0027]).

An increase in sample size is required to draw firm conclusions about bacterial pathogenesis during implant failure and apical periodontitis. Nevertheless, in this pilot molecular study, it is noted that even in the small sample set, clades of bacteria listed above were consistently overrepresented in diseased tissues. Molecular tools were useful here for revealing shifts in bacterial clades in diseased periapical tissues, but it should be noted that DNA-based detection of bacteria in these samples was difficult. Blood- and bone-derived inhibitors and the low numbers of bacterial cells in alveolar samples pose unique restrictions to molecular profiling techniques. Because the numbers of bacteria in alveolar bone were low, application of microscopy-based techniques on intact sections of alveolar bone may overcome discussed restrictions. The combination of molecular, culture and microscopy-based techniques with a larger sample cohort is required to further define the bacterial communities involved in apical periodontitis and determine whether bacteria are able to proliferate in alveolar bone, leading to early dental implant failure.

Supplementary Material
======================

###### Bacterial communities associated with apical periodontitis and dental implant failure

###### 

Click here for additional data file.
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